Zengfei Xia

HIF-1α inhibition promotes the efficacy of immune checkpoint blockade in the treatment of non-small cell lung cancer

Fan Luo, Feiteng Lu, Jiaxin Cao et al. · Cancer Letters · 2022 · 93 citations · Full text

Life Sciences, Immunology, Oncology +17

The efficacy and safety of <scp>ALK</scp> inhibitors in the treatment of <scp>ALK</scp> ‐positive non‐small cell lung cancer: A network meta‐analysis

Junsheng Fan, Tsz Hei Fong, Zengfei Xia et al. · Cancer Medicine · 2018 · 67 citations · Full text

Medicine, Oncology, Pharmacology +10

The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation

Fan Luo, Han Li, Wenjuan Ma et al. · Cellular and Molecular Immunology · 2023 · 67 citations · Full text

Medicine, Immunology, Oncology +17

Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway

Fan Luo, Feiteng Lu, Miao‐Zhen Qiu et al. · Cell Death and Disease · 2021 · 31 citations · Full text

Medicine, Oncology, Pharmacology +15

Prognostic significance of CDC25C in lung adenocarcinoma: An analysis of TCGA data

Zengfei Xia, Ting Hu, Ketao Du · Cancer Genetics · 2019 · 26 citations · Full text

Medicine, Molecular Biology, Oncology +17